Healthcare leaders adopt GenAI
What happened
- McKinsey found about 50% of U.S. healthcare leaders have implemented generative AI in their organisations. - The report also notes over 80% of organisations have deployed at least one generative AI use case. - Despite broad uptake, safety and deployment barriers remain the top concerns for healthcare leaders. (x.com)
Why it matters
Generative artificial intelligence is moving from pilot projects into day-to-day healthcare operations, with McKinsey reporting that half of U.S. healthcare leaders say their organizations have already implemented it. (mckinsey.com) McKinsey said more than 80% of surveyed organizations had deployed at least one generative artificial intelligence use case to end users, based on a survey of U.S. healthcare leaders conducted in the fourth quarter of 2025. (mckinsey.com) In plain terms, generative artificial intelligence is software that can draft text, summarize records, answer questions, or generate code from prompts, and hospitals and insurers are using it first in administrative work rather than in direct diagnosis. (mckinsey.com) McKinsey’s latest healthcare survey says leaders still rank artificial intelligence safety risks at the top of their concerns, while implementation barriers such as integration and workflow changes have risen to the same level of urgency. (mckinsey.com) That marks a shift from late 2023, when 25% of organizations reported implementation; McKinsey said the figure rose to 47% in 2024 and reached 50% by the end of 2025. (beckershospitalreview.com) McKinsey’s earlier healthcare research found 85% of respondents were exploring or already using the technology, which suggests the conversation has moved from whether to try it to how to scale it inside payers, health systems, and healthcare services and technology companies. (mckinsey.com) The wider corporate picture looks similar. In McKinsey’s 2025 global survey, companies reported broader use of generative artificial intelligence, but most said they had not yet redesigned enough workflows to capture material enterprise-level gains. (mckinsey.com) Healthcare has stronger reasons than many industries to move slowly. Patient records are regulated, billing systems are fragmented, and errors in a summary, prior-authorization draft, or clinical note can create compliance or care risks. (mckinsey.com) For now, the survey points to a sector that is no longer asking whether generative artificial intelligence belongs in healthcare, but where it can be used without adding new safety and deployment problems. (mckinsey.com)
Key numbers
- The report also notes over 80% of organisations have deployed at least one generative AI use case.
- (mckinsey.com) McKinsey said more than 80% of surveyed organizations had deployed at least one generative artificial intelligence use case to end users, based on a survey of U.S.
- healthcare leaders conducted in the fourth quarter of 2025.
- (mckinsey.com) That marks a shift from late 2023, when 25% of organizations reported implementation; McKinsey said the figure rose to 47% in 2024 and reached 50% by the end of 2025.
Quick answers
What happened in Healthcare leaders adopt GenAI?
McKinsey found about 50% of U.S. healthcare leaders have implemented generative AI in their organisations. The report also notes over 80% of organisations have deployed at least one generative AI use case. Despite broad uptake, safety and deployment barriers remain the top concerns for healthcare leaders. (x.com)
Why does Healthcare leaders adopt GenAI matter?
Generative artificial intelligence is moving from pilot projects into day-to-day healthcare operations, with McKinsey reporting that half of U.S. healthcare leaders say their organizations have already implemented it. (mckinsey.com) McKinsey said more than 80% of surveyed organizations had deployed at least one generative artificial intelligence use case to end users, based on a survey of U.S. healthcare leaders conducted in the fourth quarter of 2025. (mckinsey.com) In plain terms, generative artificial intelligence is software that can draft text, summarize records, answer questions, or generate code from prompts, and hospitals and insurers are using it first in administrative work rather than in direct diagnosis. (mckinsey.com) McKinsey’s latest healthcare survey says leaders still rank artificial intelligence safety risks at the top of their concerns, while implementation barriers such as integration and workflow changes have risen to the same level of urgency. (mckinsey.com) That marks a shift from late 2023, when 25% of organizations reported implementation; McKinsey said the figure rose to 47% in 2024 and reached 50% by the end of 2025. (beckershospitalreview.com) McKinsey’s earlier healthcare research found 85% of respondents were exploring or already using the technology, which suggests the conversation has moved from whether to try it to how to scale it inside payers, health systems, and healthcare services and technology companies. (mckinsey.com) The wider corporate picture looks similar. In McKinsey’s 2025 global survey, companies reported broader use of generative artificial intelligence, but most said they had not yet redesigned enough workflows to capture material enterprise-level gains. (mckinsey.com) Healthcare has stronger reasons than many industries to move slowly. Patient records are regulated, billing systems are fragmented, and errors in a summary, prior-authorization draft, or clinical note can create compliance or care risks. (mckinsey.com) For now, the survey points to a sector that is no longer asking whether generative artificial intelligence belongs in healthcare, but where it can be used without adding new safety and deployment problems. (mckinsey.com)
